MedTrace Logo

The Alberta BLOOM Premature Child Study

NCT05011071 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 535

Last updated 2024-12-24

No results posted yet for this study

Summary

This is a prospective, observational clinical cohort study involving 405 children born premature (at less than 37 weeks gestation) and their mother/parent/guardian. The purpose of the study is to investigate how the microbiome (the collection of microbes in a biological site) of children develops over the first years of life and its associations with the risk of childhood health outcomes including allergies and asthma. The study will also examine how perinatal factors associate with patterns of microbiome development, and their effects on the microbiome, metabolome (the collection of metabolites in a biological sample) and immune development of this population in the first years of life.

Conditions

  • Infant Conditions
  • Infant, Premature, Diseases
  • Asthma
  • Asthma in Children
  • Infant ALL
  • Allergy

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Alberta Children's Hospital Research Institute

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Marie-Claire Arrieta, PhD · University of Calgary

Eligibility

Min Age
0 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-21
Primary Completion
2027-08-31
Completion
2027-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05011071 on ClinicalTrials.gov